These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2161468)

  • 1. [Histological localization of TAG72 in gastric cancers and a clinico-pathological study of the CA72-4 serum values].
    Konishi F; Matzunou H; Konishi K; Yamamichi N
    Gan No Rinsho; 1990 May; 36(6):691-9. PubMed ID: 2161468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemical studies on tumor associated carbohydrate antigens in gastric cancers of different histological stages].
    Nakasaki H; Hanaue H; Miyaji M; Ogoshi K; Tajima T; Mitomi T; Hakomori S
    Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1458-64. PubMed ID: 1337575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
    Molinolo A; Simpson JF; Thor A; Schlom J
    Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CA72 -4 (TAG72)].
    Mizumoto Y; Kyo S; Takakura M; Nakamura M; Inoue M
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():717-9. PubMed ID: 20963906
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study on tissue polypeptide antigen (TPA) in gastric cancer].
    Kanauchi M; Sawai F; Hirayama T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
    Gan No Rinsho; 1985 Sep; 31(11):1367-71. PubMed ID: 2999464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of CA72-4 as a tumor marker in patients with gastric cancer].
    Ubukata H; Katano M; Motohashi G; Kasuga T; Takemura A; Tabuchi T; Tabuchi T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1821-4. PubMed ID: 14619529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical usefulness of serum CA72-4 analysis in patients with ovarian cancer].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):585-9. PubMed ID: 2754289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
    Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
    Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levels of circulating tumor-associated glycoprotein (TAG-72) in patients with carcinoma using a novel tumor marker, CA 72-4].
    Ohuchi N; Matoba N; Taira Y; Takahashi K; Sakai N; Sato K; Fujita N; Mochizuki F; Nishihira T; Mori S
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2767-72. PubMed ID: 3166366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA.
    Kodama I; Koufuji K; Kawabata S; Tetsu S; Tsuji Y; Takeda J; Kakegawa T
    Int Surg; 1995; 80(1):45-8. PubMed ID: 7657491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: analysis of 100 cases.
    Chen C; Chen LQ; Chen LD; Yang GL; Li Y
    Hepatogastroenterology; 2008; 55(84):991-7. PubMed ID: 18705314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor markers and gastric cancer. TAG-72 is the most useful].
    Fernández-Llamazares J; Piñol M; Encabo G; Gelonch J
    Med Clin (Barc); 1998 Dec; 111(20):800. PubMed ID: 9922976
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of gastric cancer and premalignant lesions by novel marker glycoprotein 87 using monoclonal antibody Adnab-9.
    Qiao SX; Yuan M; Liu YL; Lin XS; Zhang XP; Tobi M
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1095-9. PubMed ID: 14578149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
    Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
    Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An immunohistochemical evaluation of Warthin's tumor using the monoclonal anti-human lung adenocarcinoma antibody KM-93 and the anti-human gastric carcinoma antibody KM-231].
    Tsuji T; Kimura Y; Murakami T; Sasaki K; Shinozaki F
    Gan No Rinsho; 1990 Jun; 36(7):783-6. PubMed ID: 2355463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monoclonal antibody NCC-ST-439 in gastric cancer tissue].
    Kamata T; Yoneumura Y; Sugiyama K; Yamaguchi A; Miwa K; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1989 Feb; 90(2):222-7. PubMed ID: 2747606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mucohistochemical studies of CEA producing and non-producing stomach cancers].
    Iguchi K; Tanaka T; Yamagishi H; Inaba S; Fujimori C; Kurioka H; Kobayashi M; Hashimoto I
    Gan No Rinsho; 1983 Aug; 29(9):971-80. PubMed ID: 6194317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gastroscopy plus cytology for the diagnosis of gastric cancer or precancerous diseases--report of 127 cases].
    Zhao HY
    Zhonghua Zhong Liu Za Zhi; 1986 Mar; 8(2):115-7. PubMed ID: 3021413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multi-antibody combined determination of lymph node micrometastasis in patients with gastric cancer].
    Wang GY; Wang SJ; Li Y; Wang LL; Wang XL; Song ZC; Fan LQ
    Ai Zheng; 2004 May; 23(5):559-63. PubMed ID: 15142454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.